That's assuming we know what the agreed upon price is to them for treatment. I do not believe it would be at cost unless there is a reason to get rid of the current vials. Even at that, I do not expect them to charge poor countries as much as in the U.S. or "rich" countries like other pharma's do also. That being said, I also temper my expectation of revenues overall. (Just keeping me grounded and on earth rather than the moon).
It may be true that these countries don’t have the financial resources of a first world country. But the number of vials they can afford to buy is not zero. CYDY does not need to sell a a lot of doses to have a big impact on their overall financial situation. $100M in revenue buys a lot of financial runway to more approvals for CYDY.
Gov will pay for it , everyday in ICU in Philippine is about 20,000 USD , 6 days less on average , as per CD12 study is about 120,000. USD On Ventilator and ECMO is much more expensive.
Leronlimab will be a VERY big saving for Philippines.